Credent Connect N Care IPO Details: Key Dates, Price Band & Investment Overview

Incorporated in 2015 and headquartered in New Delhi, Credent Connect N Care Limited is a rapidly scaling, technology-enabled healthcare logistics and services enterprise. Operating under an integrated B2B model, the company delivers critical supply chain and operational solutions to diagnostic laboratories, In Vitro Diagnostics (IVD) companies, pharmaceutical firms, hospitals, and clinics across India.

• Specialized Healthcare Logistics: The company’s core competency lies in handling time-sensitive and temperature-controlled (cold chain) transportation. They securely move diagnostic samples from collection points to laboratories, as well as transport critical medical supplies and reagents for IVD companies.
• Workforce & Phlebotomy Services: Credent provides extensive diagnostic support and manpower solutions. This includes doorstep sample collection through highly trained phlebotomists, stationed phlebotomy at clinics, and supplying technical laboratory manpower.
• Proprietary Tech Platforms: The business operates through advanced in-house tech tools. This includes C3 Post, a smart courier aggregation portal designed for bulk shipments with pan-India pin-code coverage, and C3 HRMS for managing their extensive workforce.
• Corporate Wellness Programs: Through its C3 Wellness brand, the company organizes corporate health camps, vaccination drives, and preventive health check-ups.
• Scale and Network: The company has built a massive operational footprint spanning 452+ cities, supported by a network of warehouses, branch offices, and commercial vehicles. As of early 2026, the company partners with over 2,530 diagnostic laboratories and employs a massive workforce of over 6,300 people (including field staff, phlebotomists, and lab technicians). It also holds prestigious ISO 9001:2015 and ISO 15189:2022 certifications for quality management.

Because the Credent Connect N Care IPO is a 100% fresh issue, all of the ₹93.90 Crore raised will be directed into the company (and its subsidiaries) to fund expansion and operational efficiency.

The net proceeds from the IPO will be strategically deployed across the following objectives:

• Funding Working Capital (₹37.00 Crore): The largest portion of the funds will be used to meet the company's day-to-day operational expenses, support its rapidly expanding pan-India logistics network, and manage cash flow requirements seamlessly.
• Investment in Subsidiary - Working Capital (₹26.80 Crore): A significant chunk will be injected into its strategic subsidiary, Credent Healthcare Private Limited, to fund its specific working capital needs and fuel further business expansion.
• Debt Repayment (₹6.00 Crore): The company intends to fully or partially repay/pre-pay existing borrowings. This will strengthen the balance sheet and reduce their overall finance/interest costs.
• Investment in Subsidiary - Machinery (₹3.00 Crore): Funds are earmarked to purchase new machinery and equipment for Credent Healthcare Private Limited.
• General Corporate Purposes: The remaining balance of the net proceeds will be used for overarching corporate initiatives, which typically include brand building, strategic initiatives, and covering unforeseen business contingencies.